senna

CLINICAL USE

Constipation

DOSE IN NORMAL RENAL FUNCTION

Tablets: 15–30 mg (2–4 tablets) at nightGranules: 5–10 mL at nightSyrup:

10 to 20 : mL at nightManevac granules: 5–10 mL every 6–12 hours

PHARMACOKINETICS

Molecular weight :862.7

%Protein binding :Systemic bioavailability less than 5%

%Excreted unchanged in urine : No data

Volume of distribution (L/kg) :No data

half-life – normal/ESRD (hrs) :No data

DOSE IN RENAL IMPAIRMENT

GFR (mL/MIN)

20 to 50 : Dose as in normal renal function

10 to 20 : Dose as in normal renal function

<10 : Dose as in normal renal function

DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES

CAPD :Unknown dialysability. Dose as in normal renal function

HD :Unknown dialysability. Dose as in normal renal function

HDF/high flux :Unknown dialysability. Dose as in normal renal function

CAV/VVHD :Unknown dialysability. Dose as in normal renal function

IMPORTANT DRUG INTERACTIONS

Potentially hazardous interactions with other drugs

None known

ADMINISTRATION

Reconstition

–

Route

Oral

Rate of Administration

–

Comments

–

OTHER INFORMATION

Acts in 8–12 hours Syrup available, 5 mL ≡ 1 tabletGranules available, 1 × 5 mL spoonful ≡ 2 tabletsDiabetic patients should use the tablets as these have negligible sugar content.

See how to identify renal failure stages according to GFR calculation

See how to diagnose irreversible renal disease

Home